About this trial
This prospective cohort study aims to identify baseline clinical, laboratory, and radiological factors at admission that are associated with early neurological outcomes in children with encephalitis admitted to Assiut University Children Hospital.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age from 1 month to 12 years
Possible or probable encephalitis according to the International Encephalitis Consortium 2013 case definition
Written informed consent from parents or legal guardians
Disqualifiers
Pre-existing severe neurodisability pediatric modified Rankin Scale greater than or equal to 3 before the index illness
Primary diagnosis of traumatic brain injury or cerebral malaria
Known inborn error of metabolism or neurodegenerative disorder prior to the encephalitis episode
Absence of documented neurologic outcome assessment
Trial population
Children aged 1 month to 12 years admitted to Assiut University Children Hospital with possible or probable encephalitis according to the International Encephalitis Consortium 2013 case definition.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Functional neurological outcome at discharge
Score on the pediatric modified Rankin Scale at hospital discharge. The scale ranges from 0 (no symptoms) to 6 (death), with higher scores indicating worse functional outcome
Secondary outcomes
Duration of hospital stay
Length of hospital stay in days.
Need for intensive care unit admission
Number of children who require intensive care unit admission
Need for nasogastric tube feeding at discharge
Number of children who require nasogastric tube feeding at the time of hospital discharge
Nosocomial infections
Number of children who develop nosocomial infections during hospitalization
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: